Corpus Intelligence IC Memo — MINERS MEMORIAL MEDICAL CENTER 2026-04-26 12:45 UTC
IC Memo — MINERS MEMORIAL MEDICAL CENTER
Investment Committee Memorandum | PA | 49 beds | Grade C | EBITDA uplift $7.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MINERS MEMORIAL MEDICAL CENTER

CCN 390183 | SCHUYLKILL, PA | 49 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MINERS MEMORIAL MEDICAL CENTER is a 49-bed suburban community hospital in SCHUYLKILL, PA with $107.7M in net patient revenue and a 12.4% operating margin. The hospital serves a payer mix of 40.1% Medicare, 1.6% Medicaid, and 58.3% commercial.

Thesis: Turnaround. Our ML models identify $7.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.4% to 19.7% (+736bps).

Net Revenue HCRIS$107.7M
Current EBITDA COMPUTED$13.3M
Operating Margin COMPUTED12.4%
Occupancy HCRIS52.8%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS18.6%
Distress Probability ML44.5%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
86
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 12.4% places it above the state median. Among 86 size-comparable peers (24-98 beds), the median margin is 1.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MINERS MEMORIAL MEDICAL CENTER (Target)PA49$107.7M12.4%
THE GETTYSBURG HOSPITALPA76$341.8M18.4%
ST. LUKES HOSPITAL - MONROE CAPA98$221.8M7.8%
UPMC HANOVERPA73$200.8M18.2%
MEMORIAL HOSPITALPA80$184.5M13.1%
UPMC CARLISLEPA72$165.0M19.5%
OSS ORTHOPAEDIC HOSPITALPA30$149.4M-5.0%
QUAKERTOWN COMMUNITY HOSPITALPA86$146.5M5.0%
WELLSPAN SURGERY AND REHAB HOSPA25$120.2M2.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$69K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.1M
A/R Days Reduction
$1.3M
Clean Claim Rate
$69K
Total EBITDA Uplift$7.9M
Current EBITDA$13.3M
+ RCM Uplift+$7.9M
Pro Forma EBITDA$21.2M
Current Margin12.4%
Pro Forma Margin19.7%
WC Released (1x)$4.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$20.5M$167.0M8.16x52.2%
Base (11x exit)10.0x11.0x$20.5M$190.4M9.30x56.2%
Bull Case9.0x11.0x$18.4M$223.2M12.12x64.7%
Bull (12x exit)9.0x12.0x$18.4M$248.9M13.51x68.3%
Bear Case11.0x10.0x$22.5M$120.8M5.36x39.9%
Bear (11x exit)11.0x11.0x$22.5M$140.1M6.22x44.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 24-98 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-16.0% / P50=1.1% / P75=8.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.